The Uses of Anabolic Androgenic Steroids Among Athletes; Its Positive and Negative Aspects- A Literature Review

References

• Christiansen AV, Henning A, Lopez Frias FJ, Hoberman JM. Book symposium: ask vest christiansen’s gym culture, identity and performance-enhancing drugs’. 2021.
   Google Scholar
• Machek SB, Cardaci TD, Wilburn DT, Willoughby DS. Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: a narrative review. Steroids. 2020;164:108753. doi:10.1016/j.steroids.2020.108753
   PubMed Web of Science ®Google Scholar
• Bird SR, Goebel C, Burke LM, Greaves RF. Doping in sport and exercise: anabolic, ergogenic, health and clinical issues. Ann Clin Biochem. 2016;53(2):196–221. doi:10.1177/0004563215609952
   PubMed Web of Science ®Google Scholar
• Smit DL, Bond P, de Ronde W. Health effects of androgen abuse: a review of the HAARLEM study. Curr Opin Endocrinol Diabetes Obes. 2022;29(6):560–565. doi:10.1097/MED.0000000000000759
   PubMedGoogle Scholar
• Pope HG, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375. doi:10.1210/er.2013-1058
   PubMed Web of Science ®Google Scholar
• Moore E, Morrison J. In defense of medically supervised doping. J Philos Sport. 2022;49(2):159–176. doi:10.1080/00948705.2022.2066538
   Web of Science ®Google Scholar
• Grant B, Minhas S, Jayasena CN. A review of recent evidence on androgen abuse from interviews with users. Curr Opin Endocrinol Diabetes Obes. 2023;30(6):285–290. doi:10.1097/MED.0000000000000834
   PubMedGoogle Scholar
• Bhasin S, Hatfield DL, Hoffman JR, et al. Anabolic-androgenic steroid use in sports, health, and society. Med Sci Sports Exerc. 2021;53(8):1778–1794. doi:10.1249/MSS.0000000000002670
   PubMed Web of Science ®Google Scholar
• Phan J. The Role of Lipin as a Modulator of Adiposity and Energy Homeostasis: Insights from the Fatty Liver Dystrophy Mouse. Los Angeles: University of California; 2004.
   Google Scholar
• Kornbeck J. EU Antitrust Law and Sport Governance: The Next Frontier? Taylor & Francis; 2022.
   Google Scholar
• Masteralexis L. Regulating player agents. In: Research Handbook of Employment Relations in Sport. Edward Elgar, Cheltenham; 2016:99–123.
   Google Scholar
• Cowan DA, Kicman AT. Doping in sport: misuse, analytical tests, and legal aspects. Clin Chem. 1997;43(7):1110–1113. doi:10.1093/clinchem/43.7.1110
   PubMed Web of Science ®Google Scholar
• Ljungqvist A. Brief history of anti-doping. In: Acute Topics in Anti-Doping. Vol 62. Karger Publishers; 2017:1–10.
   Google Scholar
• Graham MR, Davies B, Grace FM, Kicman A, Baker JS. Anabolic steroid use: patterns of use and detection of doping. Sports Med. 2008;38(6):505–525. doi:10.2165/00007256-200838060-00005
   PubMed Web of Science ®Google Scholar
• Kornbeck J. Conclusion: EU antitrust law and the future of the sports pyramid and the ‘one federation’principle. In: EU Antitrust Law and Sport Governance. Routledge; 2022:133–157.
   Google Scholar
• Baker JS, Graham MR, Davies B. Steroid and prescription medicine abuse in the health and fitness community: a regional study. Eur J Intern Med. 2006;17(7):479–484. doi:10.1016/j.ejim.2006.04.010
   PubMed Web of Science ®Google Scholar
• Hard M. Caught in the Net: athletes’ rights and the world anti-doping agency. Cal Interdisc LJ. 2009;19:533.
   Google Scholar
• Gopinath P. Scarecrows of Chivalry: English Masculinities After Empire. University of Virginia Press; 2013.
   Google Scholar
• Mazzeo F. Anabolic steroid use in sports and in physical activity: overview and analysis. Sport Mont. 2018;16(3):113–118. doi:10.26773/smj.181020
   Google Scholar
• Brower KJ. Anabolic steroid abuse and dependence. Curr Psychiatry Rep. 2002;4(5):377–387. doi:10.1007/s11920-002-0086-6
   PubMedGoogle Scholar
• Bonnecaze AK, O’Connor T, Burns CA. Harm reduction in male patients actively using anabolic androgenic steroids (AAS) and performance-enhancing drugs (PEDs): a review. J Gen Intern Med. 2021;36(7):2055–2064. doi:10.1007/s11606-021-06751-3
   PubMed Web of Science ®Google Scholar
• Kolliari-Turner A, Oliver B, Lima G, et al. Doping practices in international weightlifting: analysis of sanctioned athletes/support personnel from 2008 to 2019 and retesting of samples from the 2008 and 2012 Olympic Games. Sports Med - Open. 2021;7(1):4. doi:10.1186/s40798-020-00293-4
   PubMedGoogle Scholar
• Bailey K, Yazdi T, Masharani U, Tyrrell B, Butch A, Schaufele F. Advantages and limitations of androgen receptor-based methods for detecting anabolic androgenic steroid abuse as performance enhancing drugs. PLoS One. 2016;11(3):e0151860. doi:10.1371/journal.pone.0151860
   PubMed Web of Science ®Google Scholar
• Chandler M, McVeigh J. Steroids and Image Enhancing Drugs 2013 Survey Results. Liverp LJMU Cent Public Health; 2014:1–26.
   Google Scholar
• Häggström M and Richfield D. Diagram of the pathways of human steroidogenesis. Wiki J Med. 2014;1(1):1–5. doi:10.15347/wjm/2014.005
   Google Scholar
• Shah RS, Patel NS, Rami NV, et al. DOPE AS A DOSE OF PHYSIOLOGICAL ENHANCERS. Pharm Global. 2016;7(3):1.
   Google Scholar
• da Justa Neves DB, Caldas ED. GC–MS quantitative analysis of black market pharmaceutical products containing anabolic androgenic steroids seized by the Brazilian Federal Police. Forensic Sci Int. 2017;275:272–281. doi:10.1016/j.forsciint.2017.03.016
   PubMed Web of Science ®Google Scholar
• Magnolini R, Falcato L, Cremonesi A, Schori D, Bruggmann P. Fake anabolic androgenic steroids on the black market–a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health. 2022;22(1):1–15. doi:10.1186/s12889-022-13734-4
   PubMed Web of Science ®Google Scholar
• Câmara LC. Anabolic androgenic steroids from underground market: drug quality and implications for research. Asian J Res Med Pharm Sci. 2023;12(3):59–64.
   Google Scholar
• Heinsvig PJ, Christiansen AV, Ayoubi D, Heisel LS, Lindholst C. Do you get what you see? The illicit doping market in Denmark—An analysis of performance and image enhancing drugs seized by the police over a 1‐year period. Drug Test Anal. 2023;15(6):668–677. doi:10.1002/dta.3472
   PubMed Web of Science ®Google Scholar
• Vanhee C, Jacobs B, Mori M, et al. Uncovering the quality deficiencies with potentially harmful effects in substandard and falsified PDE-5 inhibitors seized by Belgian controlling agencies. Forensic Sci. 2023;3(3):426–451. doi:10.3390/forensicsci3030031
   Google Scholar
• Graham MR, Ryan P, Baker JS, et al. Counterfeiting in performance‐and image‐enhancing drugs. Drug Test Anal. 2009;1(3):135–142. doi:10.1002/dta.30
   PubMed Web of Science ®Google Scholar
• Ip EJ, Doroudgar S, Lau B, Barnett MJ. Anabolic steroid users’ misuse of non-traditional prescription drugs. Res Soc Adm Pharm. 2019;15(8):949–952. doi:10.1016/j.sapharm.2018.07.003
   PubMed Web of Science ®Google Scholar
• Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521. doi:10.1038/bjp.2008.165
   PubMed Web of Science ®Google Scholar
• Kicman AT, Gower DB. Anabolic steroids in sport: biochemical, clinical and analytical perspectives. Ann Clin Biochem. 2003;40(4):321–356. doi:10.1258/000456303766476977
   PubMedGoogle Scholar
• Parr MK, Flenker U, Schänzer W. Sports-related issues and biochemistry of natural and synthetic anabolic substances. Endocrinol Metab Clin. 2010;39(1):45–57. doi:10.1016/j.ecl.2009.11.004
   Google Scholar
• Wagner U. Towards the construction of the world anti-doping agency: analyzing the approaches of FIFA and the IAAF to doping in sport. Eur Sport Manag Q. 2011;11(5):445–470. doi:10.1080/16184742.2011.624107
   Web of Science ®Google Scholar
• Challab SM, Anwer ZM, Khalil HH. Knowledge and attitude of using anabolic androgenic steroids among male bodybuilders in al-russafa baghdad province. Ibn AL-Haitham J Pure Appl Sci. 2023;36(2):22–32. doi:10.30526/36.2.3004
   Google Scholar
• de Zeeuw TI, Brunt TM, Van amsterdam J, van de Ven K, van den Brink W. Anabolic androgenic steroid use patterns and steroid use disorders in a sample of male gym visitors. Eur Addict Res. 2023;29(2):99–108. doi:10.1159/000528256
   PubMed Web of Science ®Google Scholar
• Greenway CW, Price C. Muscle dysmorphia and self-esteem in former and current users of anabolic-androgenic steroids. Perform Enhanc Health. 2020;7(3–4):100154. doi:10.1016/j.peh.2019.100154
   Google Scholar
• Mittra J, Mastroeni M, Haddow G, Wield D, Barlow E. Re-imagining healthcare and medical research systems in post-devolution Scotland. Sociol Res Online. 2019;24(1):55–72. doi:10.1177/1360780418823221
   Web of Science ®Google Scholar
• Denham BE. Anabolic steroid cases in United States district courts (2013–2017): defendant characteristics, geographical dispersion, and substance origins. Contemp Drug Prob. 2019;46(1):41–57. doi:10.1177/0091450918800823
   Google Scholar
• Gheddar L, Pélissier AL, Desfeux J, Niort F, Raul JS, Kintz P. Testing for trenbolone, an anabolic steroid, in biological fluids and head hair in a postmortem case. J Anal Toxicol. 2022;46(2):e88–e91. doi:10.1093/jat/bkab091
   Web of Science ®Google Scholar
• Harries RL, De Paoli G, Hall S, Nisbet LA. A review of the analytical techniques for the detection of anabolic–androgenic steroids within biological matrices. Wiley Interdiscip Rev Forensic Sci. 2023;e1504. doi:10.1002/wfs2.1504
   Google Scholar
• Frati P, Busardo F, Cipolloni L, De Dominicis E, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13(1):146–159. doi:10.2174/1570159X13666141210225414
   PubMed Web of Science ®Google Scholar
• Solimini R, Rotolo MC, Mastrobattista L, et al. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping. Eur Rev Med Pharmacol Sci. 2017;21(1 Suppl):1.
   PubMed Web of Science ®Google Scholar
• Wu C, Kovac JR. Novel uses for the anabolic androgenic steroids nandrolone and oxandrolone in the management of male health. Curr Urol Rep. 2016;17(10):72. doi:10.1007/s11934-016-0629-8
   PubMed Web of Science ®Google Scholar
• Cohen J, Collins R, Darkes J, Gwartney D. A league of their own: demographics, motivations and patterns of use of 1955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007;4(1):12. doi:10.1186/1550-2783-4-12
   PubMed Web of Science ®Google Scholar
• Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic‐androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014;23(4):371–377. doi:10.1111/j.1521-0391.2013.12118.x
   PubMed Web of Science ®Google Scholar
• Adams NN. A triad of physical masculinities: examining multiple ‘hegemonic’bodybuilding identities in Anabolic-Androgenic Steroid (AAS) online discussion groups. Deviant Behav. 2023;3:1–19.
   Google Scholar
• Brennan DJ, Craig SL, Thompson DEA. Factors associated with a drive for muscularity among gay and bisexual men. Cult Health Sex. 2012;14(1):1–15. doi:10.1080/13691058.2011.619578
   PubMed Web of Science ®Google Scholar
• Al-Harbi FF, Gamaleddin I, Alsubaie EG, Al-Surimi KM. Prevalence and risk factors associated with anabolic-androgenic steroid use: a cross-sectional study among gym users in Riyadh, Saudi Arabia. Oman Med J. 2020;35(2):e110. doi:10.5001/omj.2020.28
   PubMedGoogle Scholar
• Meller L, Wilson K, Huang B, Kalavacherla S, Vitale K. Underlying subclavian artery occlusion initially misdiagnosed in weightlifter using anabolic steroids: a case report and review of literature. Cureus. 2023;18. doi:10.7759/cureus.37763
   Google Scholar
• Kolliari-Turner A, Lima G, Hamilton B, Pitsiladis Y, Guppy FM. Analysis of anti-doping rule violations that have impacted medal results at the summer Olympic Games 1968–2012. Sports Med. 2021;51(10):2221–2229. doi:10.1007/s40279-021-01463-4
   PubMed Web of Science ®Google Scholar
• Salcher‐Konrad M, Naci H, Davis C. Approval of cancer drugs with uncertain therapeutic value: a comparison of regulatory decisions in Europe and the United States. Milbank Q. 2020;98(4):1219–1256. doi:10.1111/1468-0009.12476
   PubMed Web of Science ®Google Scholar
• Swaab DF. Eating disorders (Fig. 23A). 2004.
   Google Scholar
• Burrows PJ, Schrepferman CG, Lipshultz LI. Comprehensive office evaluation in the new millennium. Urol Clin. 2002;29(4):873–894. doi:10.1016/S0094-0143(02)00091-5
   PubMed Web of Science ®Google Scholar
• Evangelista M A guide on the classes of performance-enhancing substances. 2023.
   Google Scholar
• Basaria S, Wahlstrom JT, Dobs AS. Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001;86(11):5108–5117. doi:10.1210/jcem.86.11.7983
   PubMed Web of Science ®Google Scholar
• Piatkowski T, Gibbs N, Dunn M. Beyond the law: exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia. J Criminol. 2023;26338076231209044. doi:10.1177/26338076231209044
   Web of Science ®Google Scholar
• Bond P, Smit DL, de Ronde W. Anabolic–androgenic steroids: how do they work and what are the risks? Front Endocrinol. 2022;13:1059473. doi:10.3389/fendo.2022.1059473
   PubMed Web of Science ®Google Scholar
• Dubois V, Laurent M, Boonen S, Vanderschueren D, Claessens F. Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. Cell Mol Life Sci. 2012;69(10):1651–1667. doi:10.1007/s00018-011-0883-3
   PubMed Web of Science ®Google Scholar
• Santos HO, Haluch CE. Downregulation of androgen receptors upon anabolic-androgenic steroids: a cause or a flawed hypothesis of the muscle-building plateau? Muscles. 2022;1(2):92–101. doi:10.3390/muscles1020010
   Google Scholar
• Covarrubias AJ, Aksoylar HI, Horng T. Control of macrophage metabolism and activation by mTOR and Akt signaling. In: Seminars in Immunology. Vol. 27. Elsevier; 2015:286–296.
   Google Scholar
• Patt M, Beck KR, Di Marco T, et al. Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis. Biochem Pharmacol. 2020;172:113781. doi:10.1016/j.bcp.2019.113781
   PubMed Web of Science ®Google Scholar
• Park J, Mcllvain V, Rosenberg J, Donovan L, Desai P, Kim JY. The mechanisms of anabolic steroids, selective androgen receptor modulators and myostatin inhibitors. Korean J Sports Med. 2022;40(2):67–85. doi:10.5763/kjsm.2022.40.2.67
   Google Scholar
• Gao H, Zhang JY, Zhao LJ, Guo YY. Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor. Bioorg Chem. 2023;1:106998.
   Google Scholar
• Hall E, Vrolijk MF. Androgen receptor and cardiovascular disease: a potential risk for the abuse of supplements containing selective androgen receptor modulators. Nutrients. 2023;15(15):3330. doi:10.3390/nu15153330
   PubMed Web of Science ®Google Scholar
• Gu L, Yu Q, Shen Y, Wang Y, Xu Q, Zhang H. The role of monoaminergic neurons in modulating respiration during sleep and the connection with SUDEP. Biomed Pharmacother. 2022;150:112983. doi:10.1016/j.biopha.2022.112983
   PubMed Web of Science ®Google Scholar
• Carbajal-García A, Reyes-García J, Montaño LM, Llanos P. Androgen effects on the adrenergic system of the vascular, airway, and cardiac myocytes and their relevance in pathological processes. Int J Endocrinol. 2020;2020:1–25. doi:10.1155/2020/8849641
   Web of Science ®Google Scholar
• Albano GD, Amico F, Cocimano G, et al. Adverse effects of anabolic-androgenic steroids: a literature review. In: Healthcare. Vol. 9. MDPI; 2021:97.
   Google Scholar
• Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin–proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006;17(7):1807–1819. doi:10.1681/ASN.2006010083
   PubMed Web of Science ®Google Scholar
• Kraemer WJ, Duncan ND, Volek JS. Resistance training and elite athletes: adaptations and program considerations. J Orthop Sports Phys Ther. 1998;28(2):110–119. doi:10.2519/jospt.1998.28.2.110
   PubMed Web of Science ®Google Scholar
• Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281(6):E1172–E1181. doi:10.1152/ajpendo.2001.281.6.E1172
   PubMed Web of Science ®Google Scholar
• Vorona E, Nieschlag E. Abuse of Anabolic Androgenic Steroids (AAS) for Doping. In: Andrology: Male Reproductive Health and Dysfunction. Springer; 2023:585–597.
   Google Scholar
• Yu JG, Bonnerud P, Eriksson A, Stål PS, Tegner Y, Malm C. Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle. PLoS One. 2014;9:9.
   Web of Science ®Google Scholar
• Quattrocelli M, Zelikovich AS, Salamone IM, Fischer JA, McNally EM. Mechanisms and clinical applications of glucocorticoid steroids in muscular dystrophy. J Neuromuscul Dis. 2021;8(1):39–52. doi:10.3233/JND-200556
   PubMedGoogle Scholar
• Kolliari-Turner A. Anabolic Androgenic Steroid Doping in Weightlifting and the Summer Olympic Games Alongside Their Impact on Muscle Memory and the Human Transcriptome. University of Brighton; 2023.
   Google Scholar
• Zheng E, Sandhu N, Navarro V. Drug-induced liver injury secondary to herbal and dietary supplements. Clin Liver Dis. 2020;24(1):141–155. doi:10.1016/j.cld.2019.09.009
   PubMed Web of Science ®Google Scholar
• Wu S, Daston G, Rose J, et al. Identifying chemicals based on receptor binding/bioactivation/mechanistic explanation associated with potential to elicit hepatotoxicity and to support structure activity relationship-based read-across. Curr Res Toxicol. 2023;5:100108. doi:10.1016/j.crtox.2023.100108
   PubMedGoogle Scholar
• Kafrouni MI, Anders RA, Verma S. Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin Gastroenterol Hepatol. 2007;5(7):809–812. doi:10.1016/j.cgh.2007.02.036
   PubMed Web of Science ®Google Scholar
• Beyoğlu D, Idle JR. Metabolomic and lipidomic biomarkers for premalignant liver disease diagnosis and therapy. Metabolites. 2020;10(2):50. doi:10.3390/metabo10020050
   PubMed Web of Science ®Google Scholar
• Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun. 2005;328(3):688–696. doi:10.1016/j.bbrc.2004.11.097
   PubMed Web of Science ®Google Scholar
• Sun J, Tan Y, Su J, et al. Role and molecular mechanism of ghrelin in degenerative musculoskeletal disorders. J Cell Mol Med. 2023;27(23):3681–3691. doi:10.1111/jcmm.17944
   PubMed Web of Science ®Google Scholar
• Weber AE, Gallo MC, Bolia IK, Cleary EJ, Schroeder TE, Rick Hatch GF. Anabolic androgenic steroids in orthopaedic surgery: current concepts and clinical applications. JAAOS Glob Res Rev. 2022;6(1):e21.00156. doi:10.5435/JAAOSGlobal-D-21-00156
   Google Scholar
• Brodziak-Dopierała B. Lead–factors affecting its content in bone tissue. Pomeranian J Life Sci. 2020;66(4):23–29. doi:10.21164/pomjlifesci.745
   Google Scholar
• Shipov A, Zaslansky P, Riesemeier H, et al. The influence of estrogen deficiency on the structural and mechanical properties of rat cortical bone. PeerJ. 2021;9:e10213.
   PubMed Web of Science ®Google Scholar
• Vieira RP, Franca RF, Damaceno-Rodrigues NR, et al. Dose-dependent hepatic response to subchronic administration of nandrolone decanoate. Med Sci Sports Exerc. 2008;40(5):842. doi:10.1249/MSS.0b013e3181666f1c
   PubMed Web of Science ®Google Scholar
• Patanè FG, Liberto A, Maria Maglitto AN, et al. Nandrolone decanoate: use, abuse and side effects. Medicina. 2020;56(11):606. doi:10.3390/medicina56110606
   PubMedGoogle Scholar
• Hutter AM, Kayhoe DE. Adrenal cortical carcinoma: results of treatment with o, p’DDD in 138 patients. Am J Med. 1966;41(4):581–592. doi:10.1016/0002-9343(66)90220-8
   PubMed Web of Science ®Google Scholar
• Ghiacci G, Lumetti S, Manfredi E, Mori D, Macaluso GM, Sala R. Stanozolol promotes osteogenic gene expression and apposition of bone mineral in vitro. J Appl Oral Sci. 2018;4:27.
   Google Scholar
• Seynnes OR, Kamandulis S, Kairaitis R, et al. Effect of androgenic-anabolic steroids and heavy strength training on patellar tendon morphological and mechanical properties. J Appl Physiol. 2013;115(1):84–89. doi:10.1152/japplphysiol.01417.2012
   PubMed Web of Science ®Google Scholar
• Pálinkás Z, Békési D, Utczás M. Quantitation of ecdysterone and targeted analysis of WADA-prohibited anabolic androgen steroids, hormones, and metabolic modulators in ecdysterone-containing dietary supplements. Separations. 2023;10(4):242. doi:10.3390/separations10040242
   Web of Science ®Google Scholar
• Balgoma D, Zelleroth S, Grönbladh A, Hallberg M, Pettersson C, Hedeland M. Anabolic androgenic steroids exert a selective remodeling of the plasma lipidome that mirrors the decrease of the de novo lipogenesis in the liver. Metabolomics. 2020;16(1):1–13. doi:10.1007/s11306-019-1632-0
   Web of Science ®Google Scholar
• Ooi EMM. Regulation of Lipoprotein Transport in the Metabolic Syndrome: Impact of Statin Therapy. University of Western Australia; 2007.
   Google Scholar
• Kennedy MC, Lawrence C. Anabolic steroid abuse and cardiac death. Med J Aust. 1993;158(5):346–348. doi:10.5694/j.1326-5377.1993.tb121797.x
   PubMed Web of Science ®Google Scholar
• Elitok A, Öz F, Panc C, et al. Acute effects of Red Bull energy drink on ventricular repolarization in healthy young volunteers: a prospective study. Anatol J Cardiol. 2015;15(11):919. doi:10.5152/akd.2015.5791
   PubMed Web of Science ®Google Scholar
• Fadah K, Gopi G, Lingireddy A, Blumer V, Dewald T, Mentz RJ. Anabolic androgenic steroids and cardiomyopathy: an update. Front Cardiovasc Med. 2023;2023:10.
   Google Scholar
• Torrisi M, Pennisi G, Russo I, et al. Sudden cardiac death in anabolic-androgenic steroid users: a literature review. Medicina. 2020;56(11):587. doi:10.3390/medicina56110587
   PubMedGoogle Scholar
• Martins T, Vitorino R, Moreira-Gonçalves D, Amado F, Duarte JA, Ferreira R. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia. Clin Biochem. 2014;47(1–2):8–15. doi:10.1016/j.clinbiochem.2013.10.025
   PubMed Web of Science ®Google Scholar
• Bachmann KN, Huang S, Lee H, et al. Effect of testosterone on natriuretic peptide levels. J Am Coll Cardiol. 2019;73(11):1288–1296. doi:10.1016/j.jacc.2018.12.062
   PubMed Web of Science ®Google Scholar
• Rasmussen JJ, Schou M, Madsen PL, et al. Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma? J Hypertens. 2018;36(2):277–285. doi:10.1097/HJH.0000000000001546
   PubMed Web of Science ®Google Scholar
• Vanberg P, Atar D. Androgenic anabolic steroid abuse and the cardiovascular system. Doping Sport. 2010;2:411–457.
   Google Scholar
• Melchert RB, Belcher SM, Kennedy RH. Cardiovascular effects of steroidal agents. In: Cardiovascular Toxicology. CRC Press; 2008:379–440.
   Google Scholar
• Carden DL, Granger DN. Pathophysiology of ischaemia–reperfusion injury. J Pathol. 2000;190(3):255–266. doi:10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
   PubMed Web of Science ®Google Scholar
• Novák J, Bienertová-Vašků J, Kára T, Novák M. MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment. Mediators Inflamm. 2014;2014:1–14. doi:10.1155/2014/275867
   Web of Science ®Google Scholar
• Mullen C, Whalley BJ, Schifano F, Baker JS. Anabolic androgenic steroid abuse in the United Kingdom: an update. Br J Pharmacol. 2020;177(10):2180–2198. doi:10.1111/bph.14995
   PubMed Web of Science ®Google Scholar
• Turillazzi E, Perilli G, Di Paolo M, Neri M, Riezzo I, Fineschi V. Side effects of AAS abuse: an overview. Mini Rev Med Chem. 2011;11(5):374–389. doi:10.2174/138955711795445925
   PubMed Web of Science ®Google Scholar
• Lee VWS, Harris DCH. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology. 2011;16(1):30–38. doi:10.1111/j.1440-1797.2010.01383.x
   PubMed Web of Science ®Google Scholar
• Banfi G, Colombini A, Lombardi G, Lubkowska A. Metabolic markers in sports medicine. Adv Clin Chem. 2012;56(Suppl 3):1–54.
   PubMedGoogle Scholar
• Granados J, Gillum TL, Christmas KM, Kuennen MR. Prohormone supplement 3β-hydroxy-5α-androst-1-en-17-one enhances resistance training gains but impairs user health. J Appl Physiol. 2014;116(5):560–569. doi:10.1152/japplphysiol.00616.2013
   PubMed Web of Science ®Google Scholar
• Chowdhury P, Mahanta R. Effect of administration of nandrolone decanoate upon aldosterone concentration and serum na+/k+ levels in albino mice. Cardiovasc Hematol Agents Med Chem. 2016;14(3):160–166.
   Google Scholar
• Buttemer WA, Astheimer LB. Testosterone does not affect basal metabolic rate or blood parasite load in captive male white‐plumed honeyeaters Lichenostomus penicillatus. J Avian Biol. 2000;31(4):479–488. doi:10.1034/j.1600-048X.2000.310407.x
   Web of Science ®Google Scholar
• Skogastierna C, Hotzen M, Rane A, Ekström L. A supraphysiological dose of testosterone induces nitric oxide production and oxidative stress. Eur J Prev Cardiol. 2014;21(8):1049–1054. doi:10.1177/2047487313481755
   PubMed Web of Science ®Google Scholar
• Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid–induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101(5):1271–1279. doi:doi:10.1016/j.fertnstert.2014.02.002
   PubMed Web of Science ®Google Scholar
• Wood RI, Serpa RO. Anabolic-androgenic steroid abuse and cognitive impairment: testosterone IMPAIRS biconditional task performance in male rats. Behav Brain Res. 2020;379:112339. doi:10.1016/j.bbr.2019.112339
   PubMed Web of Science ®Google Scholar
• Wood RI, Wallin-Miller KG. Neurobiology of Anabolic-Androgenic Steroid Abuse. Oxford Research Encyclopedia of Neuroscience; 2019.
   Google Scholar
• Donovan A, Wood RI. Effort-based decision making in response to high-dose androgens: role of dopamine receptors. Behav Pharmacol. 2022;33(7):435–441. doi:10.1097/FBP.0000000000000687
   PubMed Web of Science ®Google Scholar
• Mhillaj E, Morgese MG, Tucci P, Bove M, Schiavone S, Trabace L. Effects of anabolic-androgens on brain reward function. Front Neurosci. 2015;9. doi:10.3389/fnins.2015.00295
   Web of Science ®Google Scholar
• Wood RI. Anabolic–androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol. 2008;29(4):490–506. doi:doi:10.1016/j.yfrne.2007.12.002
   PubMed Web of Science ®Google Scholar
• Wood RI. Reinforcing aspects of androgens. Physiol Behav. 2004;83(2):279–289. doi:doi:10.1016/j.physbeh.2004.08.012
   PubMed Web of Science ®Google Scholar
• Hauger LE, Westlye LT, Fjell AM, Walhovd KB, Bjørnebekk A. Structural brain characteristics of anabolic-androgenic steroid dependence in men . Addiction. 2019;114(8):1405–1415. doi:10.1111/add.14629
   PubMed Web of Science ®Google Scholar
• Kanayama G, Cohane GH, Weiss RD, Pope HG. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry. 2003;64(2):156–160. doi:10.4088/JCP.v64n0208
   PubMed Web of Science ®Google Scholar
• Chegeni R, Notelaers G, Pallesen S, Sagoe D. Aggression and psychological distress in male and female anabolic-androgenic steroid users: a multigroup latent class analysis. Front Psychiatry. 2021;12:629428. doi:10.3389/fpsyt.2021.629428
   PubMed Web of Science ®Google Scholar
• Nelson BS, Hildebrandt T, Wallisch P. Anabolic–androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems. Sci Rep. 2022;12(1):9133. doi:10.1038/s41598-022-13048-w
   PubMed Web of Science ®Google Scholar
• Hauger LE, Westlye LT, Fjell AM, Walhovd KB, Bjørnebekk A. Structural brain characteristics of anabolic–androgenic steroid dependence in men. Addiction. 2019;114(8):1405–1415. doi:10.1111/add.14629
   PubMed Web of Science ®Google Scholar
• Hauger LE, Havnes IA, Jørstad ML, Bjørnebekk A. Anabolic androgenic steroids, antisocial personality traits, aggression and violence. Drug Alcohol Depend. 2021;221:108604. doi:10.1016/j.drugalcdep.2021.108604
   PubMed Web of Science ®Google Scholar
• Griffiths S, Jacka B, Degenhardt L, Murray SB, Larance B. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users. Drug Alcohol Rev. 2018;37(5):664–670. doi:10.1111/dar.12688
   PubMed Web of Science ®Google Scholar
• DiFonzo N, Bordia P. Reproduced with permission of the copyright owner. Further reproduction prohibited without. J Allergy Clin Immunol. 1998;130(2):556.
   Google Scholar
• Amaral JMX, Kimergård A, Deluca P. Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis. BMJ Open. 2022;12(7):e056445. doi:10.1136/bmjopen-2021-056445
   PubMed Web of Science ®Google Scholar